Posted on October 31, 2017 by Sitemaster
A recently published study in European Urology has again (partially) validated the utility of a specific type of genomic testing as a way to project risk for progressive disease in men initially diagnosed with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: genomic, GPS, Oncotype GX, outcome, risk, test | 7 Comments »
Posted on August 8, 2017 by Sitemaster
The Intergroupe Coopérateur Francophone de Recherche en Onco-urologie (ICFuro) has just published a review of the available evidence on the clinical validity and utility of six prognostic biomarkers available for the assessment of prostate cancer-related risk. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: 4Kscore, Decipher, GPS, MiPS, Oncotype, phi, prognosis, PROLARIS, review, test | 4 Comments »